Infertility treatment center Dortmund
Dortmund, North Rhine-Westphalia, 44135, Germany
Location status: Recruiting
NCT Number: NCT06447077
The aim of this prospective multicenter study is to investigate the influence of a predetermined embryo transfer on day 6 compared to a predetermined embryo transfer on day 5. The study population consists of the control group (predetermined embryo transfer on day 5) and the study group (predetermined embryo transfer on day 6). The primary endpoint is the clinical pregnancy rate (detection of a gestational sac) per embryo transfer and the secondary endpoint is the abortion rate per clinical pregnancy. The data from the multicenter study are obtained at three test centers (Fertility Center Dortmund, Fertility Center Essen and Fertility Center Bad Münder).
Interested in participating?
Request Info18 year and older
Female
Observational
Dortmund, North Rhine-Westphalia, 44135, Germany
Location status: Recruiting
Since a predetermined embryo transfer on day 5 cannot be performed in some centers on every day of the week (e.g. sunday), some IVF centers perform a predetermined embryo transfer on day 4 or day 6, respepectively. Data for a predetermined embryo transfer on day 4 versus a predetermined embryo transfer on day 5 showed no significant differences regarding clinical pregnancy rates. However, since a day 6 transfer might offer advantages in assessing the development stage, the prolonged culture and transfer on day 6 transfer might be a very promising option.
As of yet, there are no prospective studies in the current literature examining the equivalence of a predetermined embryo transfer on day 6 versus a predetermined embryo transfer on day 5.
The aim of this prospective multicenter study is to investigate the influence of a predetermined embryo transfer on day 6 compared to a predetermined embryo transfer on day 5. The study population consists of the control group (predetermined embryo transfer on day 5) and the study group (predetermined embryo transfer on day 6). The primary endpoint is the clinical pregnancy rate (detection of a gestational sac) per embryo transfer and the secondary endpoint is the abortion rate per clinical pregnancy. The data from the multicenter study are obtained at three test centers (Fertility Center Dortmund, Fertility Center Essen and Fertility Center Bad Münder).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The patients to be included should be ≥18 years old. There is no upper age limit. Only ICSI treatments with a single embryo transfer (SET) should be included. Only the first cycle per patient should be evaluated.
Exclusion criteria
none
Time frame: 4 weeks after embryo transfer
Clinical pregnancy rate per embryo transfer (detection of a gestational sac)
Time frame: During entire ongoing pregnancy
Abortion rate per clinical pregnancy (termination of an ongoing clinical pregnancy)
Contact information is provided by the study sponsor or research team.
Stefan Dieterle, MD
CONTACT
Tom Trapphoff, DR
CONTACT
Infertility Treatment Center Dortmund
Other
Impact of a Predetermined Day 5 Embryo Transfer Versus a Predetermined Day 6 Embryo Transfer on the Clinical Pregnancy Rate After Intracytoplasmic Sperm Injection (ICSI) Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05290558
Genital Diseases, Genital Diseases, Male
Singapore
View Trial DetailsNCT07226310
Genital Diseases, Infertility
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT05440617
Acute Ovarian Failure, Early Menopause And Infertility In Females After Treatment For Childhood Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT01500447
Amenorrhea, Congenital Abnormalities
Bethesda, Maryland, United States
View Trial Details